Skip to content
Disclosery

Soleus Capital Management, L.P.

Follow

13F filer, CIK 1802630, GREENWICH, CT

Soleus Capital Management, L.P. reported $2,469,218,478 across 93 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-14. Its ten largest share positions make up 50.34% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001802630-26-000003

Period
2026-03-31
Reported value
$2.47B
Holdings
93
Top 10 weight
50.34%
New
25
Sold out
27

Largest buys vs the previous quarter

SecurityShares changeApprox. value
PODDadded+412,500$86.6M
UTHRadded+127,187$75.4M
VCELadded+1,785,079$57.4M
KRYSadded+212,028$54.8M
INDVnew+1,274,000$38.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
FOLDexited-5,207,284-$74.2M
DXCMreduced-1,157,094-$72.7M
CELCreduced-523,880-$59.8M
BMRNreduced-669,428-$37.8M
GSKexited-639,000-$31.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001802630-26-000003, largest first. % of portfolio is the value over $2,469,218,478, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 216,979 shares; 2024Q4: 358,379 shares; 2025Q1: 441,758 shares; 2025Q2: 922,958 shares; 2025Q3: 1,018,831 shares; 2025Q4: 941,059 shares; 2026Q1: 1,153,087 shares 1,153,087$298M12.06%+212,028Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,245,387 shares; 2024Q4: 2,565,087 shares; 2025Q1: 2,574,122 shares; 2025Q2: 3,011,818 shares; 2025Q3: 1,178,860 shares; 2025Q4: 1,808,258 shares; 2026Q1: 1,284,378 shares 1,284,378$147M5.94%-523,880Timeline
TGTXTG THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,534,540 shares; 2024Q4: 2,681,242 shares; 2025Q1: 2,846,703 shares; 2025Q2: 2,243,935 shares; 2025Q3: 3,844,731 shares; 2025Q4: 3,139,312 shares; 2026Q1: 4,029,319 shares 4,029,319$134M5.42%+890,007Timeline
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 16,750 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 150,000 shares; 2026Q1: 562,500 shares 562,500$118M4.78%+412,500Timeline
NVCRNOVOCURE LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 2,739,704 shares; 2025Q1: 5,521,414 shares; 2025Q2: 6,904,302 shares; 2025Q3: 9,644,872 shares; 2025Q4: 8,530,665 shares; 2026Q1: 10,492,391 shares 10,492,391$114M4.63%+1,961,726Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 101,894 shares; 2024Q4: 109,394 shares; 2025Q1: 155,394 shares; 2025Q2: 209,794 shares; 2025Q3: 150,000 shares; 2025Q4: 60,000 shares; 2026Q1: 187,187 shares 187,187$111M4.5%+127,187Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 259,398 shares; 2024Q4: 243,540 shares; 2025Q1: 1,139,740 shares; 2025Q2: 966,740 shares; 2025Q3: 859,166 shares; 2025Q4: 362,966 shares; 2026Q1: 330,517 shares 330,517$106M4.31%-32,449Timeline
VCELVERICEL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 80,696 shares; 2025Q1: not reported; 2025Q2: 50,953 shares; 2025Q3: 497,953 shares; 2025Q4: 764,000 shares; 2026Q1: 2,549,079 shares 2,549,079$82M3.32%+1,785,079Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,322,364 shares; 2026Q1: 1,970,864 shares 1,970,864$69.7M2.82%+648,500Timeline
ANIPANI PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 269,000 shares; 2024Q4: 205,294 shares; 2025Q1: 224,684 shares; 2025Q2: 50,743 shares; 2025Q3: 340,243 shares; 2025Q4: 486,243 shares; 2026Q1: 820,243 shares 820,243$63.1M2.55%+334,000Timeline
GMEDGLOBUS MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 176,000 shares; 2025Q4: 887,000 shares; 2026Q1: 729,467 shares 729,467$62.9M2.55%-157,533Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,400,000 shares; 2025Q2: 16,140,000 shares; 2025Q3: 17,290,000 shares; 2025Q4: 23,290,000 shares; 2026Q1: 41,508,659 shares 41,508,659$61.8M2.5%+18,218,659Timeline
TWSTTWIST BIOSCIENCE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 354,401 shares; 2025Q3: 1,866,234 shares; 2025Q4: 1,861,802 shares; 2026Q1: 1,226,629 shares 1,226,629$58.3M2.36%-635,173Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 183,300 shares; 2025Q1: 72,300 shares; 2025Q2: 76,493 shares; 2025Q3: not reported; 2025Q4: 910,000 shares; 2026Q1: 1,449,915 shares 1,449,915$45.7M1.85%+539,915Timeline
BBNXBETA BIONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,395,341 shares; 2025Q2: 3,820,158 shares; 2025Q3: 3,870,158 shares; 2025Q4: 2,534,565 shares; 2026Q1: 4,354,501 shares 4,354,501$43.6M1.77%+1,819,936Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 59,400 shares; 2024Q4: 76,800 shares; 2025Q1: not reported; 2025Q2: 106,750 shares; 2025Q3: 15,250 shares; 2025Q4: 70,000 shares; 2026Q1: 131,650 shares 131,650$43.6M1.76%+61,650Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,090,984 shares; 2024Q4: 2,492,000 shares; 2025Q1: 816,610 shares; 2025Q2: 1,092,110 shares; 2025Q3: 2,012,110 shares; 2025Q4: 2,247,110 shares; 2026Q1: 1,726,908 shares 1,726,908$40.3M1.63%-520,202Timeline
INDVINDIVIOR PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,274,000 shares 1,274,000$38.8M1.57%newTimeline
NPCENEUROPACE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,433,168 shares; 2024Q4: 2,433,168 shares; 2025Q1: 2,608,168 shares; 2025Q2: 2,312,957 shares; 2025Q3: 2,957,957 shares; 2025Q4: 2,703,208 shares; 2026Q1: 2,932,207 shares 2,932,207$38.6M1.56%+228,999Timeline
LIVNLIVANOVA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 117,040 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 567,500 shares; 2026Q1: 582,500 shares 582,500$37M1.5%+15,000Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 298,696 shares; 2025Q3: 148,696 shares; 2025Q4: 573,614 shares; 2026Q1: 400,306 shares 400,306$37M1.5%-173,308Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,001,400 shares; 2025Q1: 1,079,304 shares; 2025Q2: 902,304 shares; 2025Q3: 890,304 shares; 2025Q4: 1,320,000 shares; 2026Q1: 650,572 shares 650,572$36.8M1.49%-669,428Timeline
PGNYPROGYNY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,067,000 shares 2,067,000$35.1M1.42%newTimeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 39,000 shares; 2025Q2: 109,000 shares; 2025Q3: 728,188 shares; 2025Q4: 299,399 shares; 2026Q1: 576,299 shares 576,299$29.7M1.2%+276,900Timeline
FOCLEDAP TMS S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 7,309,254 shares; 2024Q4: 7,309,254 shares; 2025Q1: 7,309,254 shares; 2025Q2: 7,309,254 shares; 2025Q3: 7,309,254 shares; 2025Q4: 7,309,254 shares; 2026Q1: 7,309,254 shares 7,309,254$27.2M1.1%0Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 302,500 shares; 2024Q4: not reported; 2025Q1: 469,500 shares; 2025Q2: 254,689 shares; 2025Q3: 150,000 shares; 2025Q4: 587,000 shares; 2026Q1: 521,353 shares 521,353$25.1M1.02%-65,647Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 203,000 shares 203,000$24.4M0.99%newTimeline
ORGOORGANOGENESIS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 11,839,876 shares; 2024Q4: 12,484,876 shares; 2025Q1: 12,478,351 shares; 2025Q2: 12,343,351 shares; 2025Q3: 12,131,699 shares; 2025Q4: 9,985,951 shares; 2026Q1: 10,085,951 shares 10,085,951$23.9M0.97%+100,000Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 29,900 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 119,000 shares 119,000$23.8M0.96%+99,000Timeline
AXGNAXOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,005,943 shares; 2024Q4: 2,955,943 shares; 2025Q1: 1,446,117 shares; 2025Q2: 1,459,395 shares; 2025Q3: 1,726,553 shares; 2025Q4: 1,206,855 shares; 2026Q1: 679,170 shares 679,170$22.5M0.91%-527,685Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 27,050 shares; 2024Q4: 99,050 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 608,958 shares; 2026Q1: 385,472 shares 385,472$22.4M0.91%-223,486Timeline
ICLRICON PUB LTD COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 192,000 shares 192,000$21.2M0.86%newTimeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 598,169 shares; 2024Q4: 814,652 shares; 2025Q1: 814,652 shares; 2025Q2: 732,968 shares; 2025Q3: 647,052 shares; 2025Q4: 702,052 shares; 2026Q1: 702,052 shares 702,052$19.8M0.8%0Timeline
CERSCERUS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,000,000 shares; 2026Q1: 10,753,700 shares 10,753,700$19.6M0.79%+6,753,700Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 700,000 shares; 2025Q3: 25,000 shares; 2025Q4: 900,000 shares; 2026Q1: 1,620,000 shares 1,620,000$19.3M0.78%+720,000Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 6,325,000 shares; 2025Q1: 6,325,000 shares; 2025Q2: 6,325,000 shares; 2025Q3: 6,325,000 shares; 2025Q4: 10,875,000 shares; 2026Q1: 10,875,000 shares 10,875,000$18.3M0.74%0Timeline
CNTXCONTEXT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,963,141 shares 6,963,141$18.2M0.74%newTimeline
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,002,000 shares 2,002,000$17.9M0.73%newTimeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 78,800 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 292,000 shares 292,000$17M0.69%newTimeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 546,000 shares 546,000$16.2M0.66%newTimeline
TNDMTANDEM DIABETES CARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 496,039 shares; 2025Q2: 200,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 783,000 shares 783,000$15M0.61%newTimeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,065,834 shares; 2024Q4: 2,102,833 shares; 2025Q1: 2,422,833 shares; 2025Q2: 2,422,833 shares; 2025Q3: 2,422,833 shares; 2025Q4: 1,219,394 shares; 2026Q1: 938,163 shares 938,163$14.5M0.59%-281,231Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 2,185,000 shares; 2025Q3: 679,000 shares; 2025Q4: 150,000 shares; 2026Q1: 727,000 shares 727,000$13.1M0.53%+577,000Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 240,000 shares; 2025Q2: 376,000 shares; 2025Q3: 413,500 shares; 2025Q4: 268,500 shares; 2026Q1: 293,500 shares 293,500$11.8M0.48%+25,000Timeline
CORTCORCEPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 285,531 shares 285,531$11.5M0.47%newTimeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 796,744 shares; 2025Q3: 796,744 shares; 2025Q4: 796,744 shares; 2026Q1: 796,744 shares 796,744$11.2M0.45%0Timeline
VCYTVERACYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 54,303 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 715,439 shares; 2025Q3: 422,055 shares; 2025Q4: 10,000 shares; 2026Q1: 319,912 shares 319,912$10.3M0.42%+309,912Timeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 7,708,727 shares; 2026Q1: 7,708,727 shares 7,708,727$10M0.41%0Timeline
CCCCC4 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 6,603,996 shares; 2024Q4: 6,978,942 shares; 2025Q1: 6,978,942 shares; 2025Q2: 6,978,942 shares; 2025Q3: 7,053,942 shares; 2025Q4: 3,803,942 shares; 2026Q1: 3,803,942 shares 3,803,942$10M0.41%0Timeline
KIDSORTHOPEDIATRICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 288,945 shares; 2024Q4: not reported; 2025Q1: 45,000 shares; 2025Q2: 45,000 shares; 2025Q3: 128,000 shares; 2025Q4: 525,447 shares; 2026Q1: 615,447 shares 615,447$9.77M0.4%+90,000Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 711,983 shares; 2026Q1: 451,983 shares 451,983$9.76M0.4%-260,000Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 343,152 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 730,000 shares; 2025Q3: 300,000 shares; 2025Q4: 10,000 shares; 2026Q1: 450,000 shares 450,000$9.41M0.38%+440,000Timeline
EOLSEVOLUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,037,680 shares; 2024Q4: 697,158 shares; 2025Q1: 1,079,158 shares; 2025Q2: 2,119,000 shares; 2025Q3: 1,450,000 shares; 2025Q4: 1,070,000 shares; 2026Q1: 2,245,360 shares 2,245,360$9.23M0.37%+1,175,360Timeline
SOPHSOPHIA GENETICS SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,850,000 shares 1,850,000$9.16M0.37%newTimeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 239,705 shares; 2024Q4: 75,405 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,025,000 shares; 2026Q1: 230,869 shares 230,869$9.05M0.37%-794,131Timeline
INBXINHIBRX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,000 shares; 2026Q1: 131,000 shares 131,000$8.81M0.36%+106,000Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,297,094 shares; 2026Q1: 140,000 shares 140,000$8.79M0.36%-1,157,094Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 675,409 shares; 2025Q1: 751,353 shares; 2025Q2: 75,456 shares; 2025Q3: 18,260 shares; 2025Q4: 383,368 shares; 2026Q1: 275,000 shares 275,000$6.61M0.27%-108,368Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 441,978 shares; 2026Q1: 441,978 shares 441,978$6.6M0.27%0Timeline
BDSXBIODESIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 416,599 shares 416,599$6.04M0.24%newTimeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 842,106 shares 842,106$5.86M0.24%newTimeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 410,200 shares 410,200$5.83M0.24%newTimeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 9,678 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,110,000 shares; 2026Q1: 230,000 shares 230,000$5.71M0.23%-880,000Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 275,000 shares; 2025Q4: 408,900 shares; 2026Q1: 178,897 shares 178,897$5.34M0.22%-230,003Timeline
IMUXIMMUNIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 7,293,007 shares; 2024Q4: 7,293,007 shares; 2025Q1: 7,293,007 shares; 2025Q2: 7,293,007 shares; 2025Q3: 1,580,007 shares; 2025Q4: not reported; 2026Q1: 4,500,000 shares 4,500,000$5M0.2%newTimeline
LRMRLARIMAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,066,960 shares 1,066,960$4.8M0.19%newTimeline
ETONETON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 285,000 shares; 2025Q3: 200,000 shares; 2025Q4: not reported; 2026Q1: 166,381 shares 166,381$4.11M0.17%newTimeline
SABSSAB BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,050,000 shares 1,050,000$4.02M0.16%newTimeline
PRCTPROCEPT BIOROBOTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 160,000 shares 160,000$4M0.16%newTimeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 90,000 shares; 2026Q1: 80,000 shares 80,000$3.86M0.16%-10,000Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 31,841 shares; 2025Q1: 76,841 shares; 2025Q2: 76,841 shares; 2025Q3: 25,000 shares; 2025Q4: not reported; 2026Q1: 121,684 shares 121,684$3.76M0.15%newTimeline
LUNGPULMONX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,038,323 shares; 2026Q1: 2,788,323 shares 2,788,323$3.6M0.15%+750,000Timeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 8,528,500 shares; 2024Q4: 6,560,000 shares; 2025Q1: 7,785,000 shares; 2025Q2: 3,261,707 shares; 2025Q3: 976,707 shares; 2025Q4: not reported; 2026Q1: 1,000,000 shares 1,000,000$3.51M0.14%newTimeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 28,940 shares; 2025Q2: 42,876 shares; 2025Q3: 69,426 shares; 2025Q4: 31,726 shares; 2026Q1: 3,500 shares 3,500$2.56M0.1%-28,226Timeline
KPTIKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 440,000 shares; 2026Q1: 440,000 shares 440,000$2.45M0.1%0Timeline
MSLESATELLOS BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 414,359 shares 414,359$2.33M0.09%newTimeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 28,479 shares 28,479$1.79M0.07%newTimeline
NSPRINSPIREMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,378,128 shares; 2024Q4: 1,378,128 shares; 2025Q1: 945,376 shares; 2025Q2: 1,886,207 shares; 2025Q3: 1,470,934 shares; 2025Q4: 1,150,000 shares; 2026Q1: 1,045,708 shares 1,045,708$1.7M0.07%-104,292Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 30,272 shares; 2024Q4: 320,272 shares; 2025Q1: 274,272 shares; 2025Q2: 72,772 shares; 2025Q3: 2,550 shares; 2025Q4: 48,500 shares; 2026Q1: 10,250 shares 10,250$1.68M0.07%-38,250Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,304,300 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 300,000 shares 300,000$1.41M0.06%newTimeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 340,585 shares; 2024Q4: 328,585 shares; 2025Q1: 303,585 shares; 2025Q2: 155,000 shares; 2025Q3: 290,000 shares; 2025Q4: 170,000 shares; 2026Q1: 20,000 shares 20,000$1.35M0.05%-150,000Timeline
NEONEOGENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 427,504 shares; 2026Q1: 175,000 shares 175,000$1.3M0.05%-252,504Timeline
QNRXQUOIN PHARMACEUTICALS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,000 shares; 2026Q1: 72,730 shares 72,730$480K0.02%+47,730Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 120,000 shares; 2026Q1: 10,000 shares 10,000$385K0.02%-110,000Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 125,000 shares; 2026Q1: 10,000 shares 10,000$383K0.02%-115,000Timeline
STAASTAAR SURGICAL COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,562,893 shares; 2025Q2: 2,984,733 shares; 2025Q3: 500,000 shares; 2025Q4: 25,000 shares; 2026Q1: 20,000 shares 20,000$374K0.02%-5,000Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 414,000 shares; 2025Q1: 102,052 shares; 2025Q2: 321,040 shares; 2025Q3: 626,040 shares; 2025Q4: 135,000 shares; 2026Q1: 6,000 shares 6,000$333K0.01%-129,000Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 80,000 shares; 2025Q4: not reported; 2026Q1: 10,000 shares 10,000$313K0.01%newTimeline
RIGLRIGEL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 934,788 shares; 2024Q4: 1,130,679 shares; 2025Q1: 1,130,679 shares; 2025Q2: 658,145 shares; 2025Q3: 330,010 shares; 2025Q4: 300,034 shares; 2026Q1: 10,000 shares 10,000$270K0.01%-290,034Timeline
ZYMEZYMEWORKS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,000 shares; 2026Q1: 10,000 shares 10,000$250K0.01%-90,000Timeline
LBRXLB PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 400,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares 10,000$247K0.01%0Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 190,000 shares; 2026Q1: 5,000 shares 5,000$245K0.01%-185,000Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,343,665 shares; 2024Q4: 1,494,420 shares; 2025Q1: 1,494,420 shares; 2025Q2: 1,494,420 shares; 2025Q3: 1,494,420 shares; 2025Q4: 200,000 shares; 2026Q1: 276,312 shares 276,312$242K0.01%+76,312Timeline

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
XBISPDR SERIES TRUST2,900,000$354Mput
FOLDAMICUS THERAPEUTIC5,207,284$74.2Mshares
GSKGSK PLC639,000$31.3Mshares
RAPTRAPT THERAPEUTICS INC764,000$25.9Mshares
NBIXNEUROCRINE BIOSCIENCES INC175,982$25Mshares
TFXTELEFLEX INCORPORATED190,000$23.2Mshares
CAPRCAPRICOR THERAPEUTICS INC646,390$18.7Mshares
THCTENET HEALTHCARE CORP92,500$18.4Mshares
TERNTERNS PHARMACEUTICALS INC212,710$8.59Mshares
CDTXCIDARA THERAPEUTICS INC38,811$8.57Mshares
ERASERASCA INC2,162,162$8.04Mshares
BLTEBELITE BIO INC40,354$6.46Mshares
ABVXABIVAX SA45,000$6.07Mshares
MLTXMOONLAKE IMMUNOTHERAPEUTICS400,000$5.27Mshares
CALCCALCIMEDICA INC683,904$4.51Mshares
INDIVIOR PLCINDIVIOR PLC100,000$3.59Mshares
VKTXVIKING THERAPEUTICS INC70,000$2.46Mshares
QDELQUIDELORTHO CORP75,000$2.14Mshares
ACLXARCELLX INC30,000$1.96Mshares
OLMAOLEMA PHARMACEUTICALS INC69,874$1.75Mshares
BCAXBICARA THERAPEUTICS INC100,000$1.68Mshares
KODKODIAK SCIENCES INC60,000$1.68Mshares
GRALGRAIL INC11,000$941Kshares
GUTSFRACTYL HEALTH INC400,000$880Kshares
MDGLMADRIGAL PHARMACEUTICALS INC500$291Kshares
DYNDYNE THERAPEUTICS INC10,000$196Kshares
DCTHDELCATH SYS INC10,000$101Kshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001802630-26-000003 base2026-05-14acceptance time not in the bulk data set